[
  {
    "title": "Bristol-Myers Squibb Company (BMY): Among Incredibly Cheap Dividend Stock to Buy Now",
    "published": 1742577940
  },
  {
    "title": "Is Bristol-Myers Squibb Company (BMY) The Best Undervalued Stock to Buy According to Billionaires?",
    "published": 1742482746
  },
  {
    "title": "Is Bristol-Myers Squibb (BMY) the Most Undervalued Biotech Stock to Invest In?",
    "published": 1742394833
  },
  {
    "title": "Bristol-Myers Squibb Company (BMY): A Bull Case Theory",
    "published": 1742232900
  },
  {
    "title": "EC approves Bristol Myers Squibb\u2019s follicular lymphoma CAR T therapy",
    "published": 1742203332
  },
  {
    "title": "Why Bristol-Myers Squibb Company (BMY) Went Down On Friday?",
    "published": 1742022159
  },
  {
    "title": "Bristol-Myers Squibb (NYSE:BMY) Gets EC Nod For Breyanzi In NHL Treatment",
    "published": 1741973244
  },
  {
    "title": "Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma",
    "published": 1741949940
  },
  {
    "title": "Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.",
    "published": 1741944600
  },
  {
    "title": "Gilead (GILD) Up 10.3% Since Last Earnings Report: Can It Continue?",
    "published": 1741879829
  },
  {
    "title": "Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy According to Hedge Funds?",
    "published": 1741804361
  },
  {
    "title": "Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know",
    "published": 1741784414
  },
  {
    "title": "BMS to acquire longtime cell therapy partner 2seventy bio for $286m",
    "published": 1741730248
  },
  {
    "title": "TSVT Up on Acquisition Agreement With BMY for $286 Million",
    "published": 1741719600
  },
  {
    "title": "2seventy bio, Bluebird\u2019s cell therapy spinout, sells to Bristol Myers for less than $300M",
    "published": 1741691100
  }
]